Other Sellers on Amazon
Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required. Learn more
Read instantly on your browser with Kindle Cloud Reader.
Using your mobile phone camera - scan the code below and download the Kindle app.
Enter your mobile phone or email address
By pressing "Send link," you agree to Amazon's Conditions of Use.
You consent to receive an automated text message from or on behalf of Amazon about the Kindle App at your mobile number above. Consent is not a condition of any purchase. Message & data rates may apply.
Follow the Author
China Rx: Exposing the Risks of America's Dependence on China for Medicine Hardcover – April 17, 2018
Enhance your purchase
Books with Buzz
Discover the latest buzz-worthy books, from mysteries and romance to humor and nonfiction. Explore more
Frequently bought together
—Michael T. Osterholm, Regents Professor, University of Minnesota, and author of Deadliest Enemy: Our War against Killer Germs
"In this alarming exposé, Gibson and Singh explain why the fact that the U.S. no longer makes penicillin and China supplies most of the ingredients in today’s prescription drugs is such a big problem and a threat to national security.... Readers will want to do more due diligence on the provenance of the drugs in their home medicine cabinets."
“China Rx describes a major threat to the strategic position of the United States in the world, a matter affecting this country’s health and its economic and social well-being. This book reveals how the loss of the manufacturing capability and control of the supply of critical medicines, and their component ingredients, endangers the medical future of the American public while also posing a serious threat to our economy as well. The authors prescribe what must be done to remedy this major deficiency in our nation’s public health infrastructure.”
—Edwin Meese III, 75th United States attorney general
“China Rx exposes the scary truth that a great number of prescription drugs and over-the-counter medicines in the United States have ingredients from China. There should be tougher import standards, a requirement for pharmaceutical companies to label a drug’s origins, and a reversal of US dependence on China.”
—Jim Guest, former president, Consumer Reports
“Everyone who has ever taken a pill needs to read this book. The American people won’t be happy when they find out that many of the medicines they rely on are being made in China where regulations aren’t enforced and/or documents are falsified.”
—Leo W. Gerard, international president, United Steelworkers
“Rosemary Gibson and Janardan Prasad Singh do an outstanding job of guiding the reader through the inherent risk to the United States to become dependent on any one country, such as China, as a source for vital medicines, and the risks from weak enforcement of safety standards and quality control by foreign manufacturers.”
—Maj. Gen. Larry J. Lust, US Army (ret.)
“A compelling book that reveals America’s troubling dependence on China for essential medicines and the pattern in US-China trade where intellectual property and value-added production are shifted to China to the detriment of US workers, businesses, national security, and the health of our citizens.”
—Daniel Slane, commissioner, US-China Economic and Security Review Commission
“A wake-up call for the public and policy makers to bring drug manufacturing home, safeguard American jobs, and strengthen national security.”
—Scott N. Paul, president, Alliance for American Manufacturing
“The authors tell how the institutions we trust have sold out to China and thrown American patients under the bus! As a quality professional, I am appalled that so many people care more about cost than the quality of our medicines. China Rx would make a great suspense thriller movie.”
—Martin VanTrieste, former chief quality officer, Amgen
About the Author
Janardan Prasad Singh is economic advisor at the World Bank. He designs strategies to strengthen economic development, health care, global trade, and national security for countries around the world. He has served as an advisor to prime ministers of India on national security affairs. Formerly, he was a member of the Board of Contributors of the Wall Street Journal.
- Publisher : Prometheus; 1st Edition (April 17, 2018)
- Language : English
- Hardcover : 304 pages
- ISBN-10 : 1633883817
- ISBN-13 : 978-1633883819
- Item Weight : 1.14 pounds
- Dimensions : 6.38 x 1.05 x 9.26 inches
- Best Sellers Rank: #129,111 in Books (See Top 100 in Books)
- Customer Reviews:
About the author
Reviews with images
Top reviews from the United States
There was a problem filtering reviews right now. Please try again later.
I also had not been following the travails of the US FDA in managing to conduct inspections of Chinese pharma companies, and I was also not ready to read that the entire inspection and surveillance schemes are broken.
Rosemary Gibson lays out a 10-point plan to get American pharma back in the manufacturing business, if for no other reason than it would seem to be a national security imperative.
I was quoted briefly in the book, but even though I myself am involved in Chinese biotech and pharma, I could not see the forest for the trees, and this book has done much to lift me out of the woods on several critical topics.
ONE WONDERS IF THE SIDE EFFECTS SUFFERED ARE DUE TO CONTAMINATION OF DRUGS? DO YOU REALLY THINK OUR GOVERNMENT CARES ABOUT AMERICAN HEALTH--WHAT ABOUT THE VAST KILLING EFFECTS OF GOVERNMENT APPROVED DRUGS OF CIGARETTES & ALCOHOL? ALSO DOCUMENTED IS HOW QUICKLY CHINA IS CONTROLLING OUR MEDICINES THROUGH COMMUNIST FRIENDLY PRESIDENTS. THIS IS A MUST READ.
Top reviews from other countries
Must read for those ordinary Americans and those working for the FDA.
The 10 action points in the last chapter are critical for American national security.